John Bernard Payne - Net Worth and Insider Trading
John Bernard Payne Net Worth
The estimated net worth of John Bernard Payne is at least $157,626 dollars as of 2024-11-07. John Bernard Payne is the President and CEO of Zivo Bioscience Inc and owns about 7,909 shares of Zivo Bioscience Inc (ZIVO) stock worth over $157,626. Details can be seen in John Bernard Payne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Bernard Payne has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Bernard Payne
John Bernard Payne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Bernard Payne owns 2 companies in total, including Nexvet Biopharma PLC (NVET) , and Zivo Bioscience Inc (ZIVO) .
Click here to see the complete history of John Bernard Payne’s form 4 insider trades.
Insider Ownership Summary of John Bernard Payne
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVET | Nexvet Biopharma PLC | 2017-07-31 | director |
| ZIVO | Zivo Bioscience Inc | 2024-10-16 | director |
John Bernard Payne Latest Holdings Summary
John Bernard Payne currently owns a total of 1 stock. John Bernard Payne owns 7,909 shares of Zivo Bioscience Inc (ZIVO) as of October 16, 2024, with a value of $157,626.
Latest Holdings of John Bernard Payne
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZIVO | Zivo Bioscience Inc | 2024-10-16 | 7,909 | 19.93 | 157,626 |
Holding Weightings of John Bernard Payne
John Bernard Payne Form 4 Trading Tracker
According to the SEC Form 4 filings, John Bernard Payne has made a total of 3 transactions in Zivo Bioscience Inc (ZIVO) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Zivo Bioscience Inc is the acquisition of 6,343 shares on October 16, 2024, which cost John Bernard Payne around $99,966.
Insider Trading History of John Bernard Payne
- 1
John Bernard Payne Trading Performance
GuruFocus tracks the stock performance after each of John Bernard Payne's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Bernard Payne is 25.1%. GuruFocus also compares John Bernard Payne's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Bernard Payne within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Bernard Payne's insider trading performs compared to the benchmark.
Performance of John Bernard Payne
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.75 | | | | | |
| Relative Return to S&P 500(%) | 13.1 | | | | | |
John Bernard Payne Ownership Network
Ownership Network List of John Bernard Payne
Ownership Network Relation of John Bernard Payne
John Bernard Payne Owned Company Details
What does Nexvet Biopharma PLC do?
Who are the key executives at Nexvet Biopharma PLC?
John Bernard Payne is the director of Nexvet Biopharma PLC. Other key executives at Nexvet Biopharma PLC include 10 percent owner & other: Member of Group Owning 10% Philip D Dreyfuss , 10 percent owner & other: Member of Group Owning 10% William Seybold , and 10 percent owner & other: Member of Group Owning 10% Ravi K Paidipaty .
Nexvet Biopharma PLC (NVET) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Nexvet Biopharma PLC (NVET) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nexvet Biopharma PLC (NVET) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Nexvet Biopharma PLC (NVET)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nexvet Biopharma PLC Insider Transactions
John Bernard Payne Mailing Address
Above is the net worth, insider trading, and ownership report for John Bernard Payne. You might contact John Bernard Payne via mailing address: 9900 Ne 114th Circle, Vancouver Wa 98662.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
